Raymond James Upgrades CME Group (NASDAQ:CME) to Outperform
CME Group (NASDAQ:CME – Get Free Report) was upgraded by equities researchers at Raymond James from a “market perform” rating to an “outperform” rating in a note issued to investors on Monday, Marketbeat.com reports. The brokerage currently has a $287.00 price target on the financial services provider’s stock. Raymond James’ price objective would indicate a […]
CME Group (NASDAQ:CME – Get Free Report) was upgraded by equities researchers at Raymond James from a “market perform” rating to an “outperform” rating in a note issued to investors on Monday, Marketbeat.com reports. The brokerage currently has a $287.00 price target on the financial services provider’s stock. Raymond James’ price objective would indicate a […]
